Polar Asset Management Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Buy |
+9,600
| New | +$3.13M | 0.05% | 235 |
|
|
2024
Q4 | – | Sell |
-5,900
| Closed | -$1.62M | – | 633 |
|
|
2024
Q3 | $1.62M | Sell |
5,900
-4,100
| -41% | -$1.13M | 0.03% | 344 |
|
|
2024
Q2 | $2.43M | Sell |
10,000
-12,600
| -56% | -$3.06M | 0.05% | 271 |
|
|
2024
Q1 | $3.38M | Buy |
+22,600
| New | +$3.38M | 0.06% | 261 |
|
|
2022
Q4 | – | Sell |
-19,600
| Closed | -$3.92M | – | 1185 |
|
|
2022
Q3 | $3.92M | Buy |
+19,600
| New | +$3.92M | 0.05% | 523 |
|